company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1631400.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1631400.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,48784.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,323483.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-244759.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1503892.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1503892.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21187.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-35060.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-56247.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-56247.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,342654.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,342654.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,342654.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1829.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1215656.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1380633.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1380633.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,40530.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,471646.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-838849.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1707306.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1707306.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-97910.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-46554.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-144464.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-144464.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5079851.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5079851.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5079851.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9521.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3218560.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1554097.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1554097.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,36348.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,407581.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-241102.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1351270.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1351270.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-73835.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-66766.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,30000.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-110601.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-110601.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,21280849.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,438849.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,21719698.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,21719698.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3048.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20260875.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1299259.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1299259.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,44591.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,579660.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-603673.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1278681.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1278681.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-56018.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-40330.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15053981.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15150329.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15150329.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-131.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,220909.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,220778.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,220778.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-184.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16208416.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-153931.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-153931.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,46704.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9761.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,383885.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2124831.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2411250.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2411250.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-122776.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-77610.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-200386.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-200386.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,47536.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47536.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47536.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-19300.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2239100.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74394.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74394.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,46246.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,511716.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1999624.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1516056.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1516056.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-205345.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-21711.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3008366.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3000000.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-235422.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-235422.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,554024.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,554024.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,554024.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,7107.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1190347.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2807072.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2807072.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29016.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,461740.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2271197.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4587513.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4587513.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-105168.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-119583.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3025802.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3000000.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-250553.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-250553.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4684153.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4684153.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4684153.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-40534.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-194447.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3534239.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3534239.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,102768.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,490769.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1067410.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1873292.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1873292.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2114941.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-142577.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9043008.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3000000.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8300526.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8300526.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4334630.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4334630.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4334630.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,25952.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5813236.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5011745.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5011745.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,52998.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,66324.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,680736.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1715560.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2496127.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2496127.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-831178.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,39110.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15089063.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3000000.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12881131.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12881131.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,53328188.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2035522.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,55305878.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,55305878.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8542.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39937162.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3408448.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3408448.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,74618.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,60087.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,451276.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1220676.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4043143.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4043143.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-763600.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-38100.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9118161.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9919861.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9919861.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1260.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1260.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1260.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-6745.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13971009.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5103256.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5103256.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,85117.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,58239.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,431322.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-128318.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4656896.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4656896.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1044132.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-51678.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3000000.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1904190.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1904190.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,542586.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,542586.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,542586.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-963.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2211083.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6359957.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6359957.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,128453.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,55982.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,651502.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,930032.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4593988.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4593988.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-376836.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-105780.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12000000.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11517384.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11517384.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,110956.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,110956.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,110956.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,11162.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7045514.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5635115.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5635115.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,205070.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,100771.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,901160.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2753990.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1674124.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1674124.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-558685.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-224775.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12011374.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9000000.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3794834.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3794834.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1570227.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1570227.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1570227.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5481.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3893250.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8794605.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8794605.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,224753.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,15111.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,621427.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,972426.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6960888.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6960888.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-128701.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-42259.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6000000.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5829040.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5829040.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1121812.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1121812.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1121812.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,250.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9786.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9097725.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9097725.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,279033.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2476.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,582169.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2056010.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6178037.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6178037.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-789636.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-210321.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9000000.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8000043.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8000043.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,139516.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,139516.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,139516.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-997.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1960525.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7186441.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7186441.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,369372.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1672.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,694645.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1217934.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7338686.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7338686.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1911401.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-209363.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6000000.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3879236.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3879236.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1492815.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1492815.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1492815.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-508.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1967143.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10072944.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10072944.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,351059.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,777.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4316484.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-451066.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5855690.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5855690.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1833575.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-527847.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3000000.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,638578.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,638578.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,196562.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,196562.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,196562.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1393.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5021943.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6787674.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6787674.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,378555.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1414.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,733695.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4984223.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10658233.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10658233.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1889615.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-927631.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3000000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,182754.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,182754.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11277.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11277.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11277.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,891.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10485865.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1506646.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1506646.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,390376.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2410.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1084320.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9175285.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9204825.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9204825.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2201704.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-32629.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15037675.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3000000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14272008.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14272008.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,43115000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,79201.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,43058353.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,43058353.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,91.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19581611.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5738041.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5738041.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,400814.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3246.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,998144.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1651700.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5987537.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5987537.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-921693.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-48103.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-969796.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-969796.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-284169.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-284169.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2175.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7243677.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6626639.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6626639.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,400255.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,33930.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1709841.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2134208.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2348405.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2348405.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-629988.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-34637.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-325.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-664950.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-664950.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,31093.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,31093.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,193.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2982069.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7656110.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7656110.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,413545.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3225.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,535819.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2739715.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3963806.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3963806.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1766979.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-32517.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3000000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1200504.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1200504.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-34476.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-34476.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-34476.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1246.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2796532.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6061463.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6061463.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,477843.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4573.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,759243.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,100484.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4719320.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4719320.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-788195.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6502.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3000000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2205303.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2205303.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-29620.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-29620.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-29620.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,701.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2542936.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6120983.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6120983.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,480150.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3115.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,609546.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2015065.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3013107.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3013107.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1723469.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-64769.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6000000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4211762.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4211762.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,24071.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,24071.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,24071.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-507.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1222219.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4500444.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4500444.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,489462.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-10913.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1051392.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-528264.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3498767.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3498767.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-601357.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-23212.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3000000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2375431.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2375431.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,57025.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,57025.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,57025.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1440.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1066751.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4736000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4736000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,494000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,536000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-276000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3982000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3982000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-427000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-9000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-436000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-436000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,381000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,381000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,381000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4038000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2840000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2840000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,477000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,49000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,762000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4561000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6113000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6113000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-102000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-48000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9964000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10114000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10114000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-241000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,25000000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1209000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,25968000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,25968000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9741000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5452000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5452000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,549000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-31000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1139000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1592000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5387000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5387000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-350000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-26000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-376000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-376000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-52000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-169000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-221000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-221000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5984000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3715000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3715000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,584000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-18000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1936000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6399000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7612000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7612000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-288000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-18000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1901000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6595000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6595000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,146000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,145000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,145000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-871000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1080000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6193000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6193000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,604000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1058000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1498000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6029000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6029000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-61000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-10000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2750000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2679000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2679000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-102000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-102000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-102000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3451000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4520000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4520000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,603000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1086000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1222000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4053000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4053000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-275000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-9000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,4750000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9466000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9466000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,258000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,258000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,258000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5671000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1148000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1936000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1936000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,601000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1741000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-484000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-78000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-78000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-190000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-21000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-211000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-211000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-333000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-333000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-333000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-622000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,604000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6134000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6134000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,916000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-15593000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1381000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7162000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7162000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-328000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-328000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-328000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7114000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,108000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7222000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7222000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-269000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,601000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5539000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5539000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,678000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2363000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9492000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11990000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11990000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-391000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-391000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-391000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7785000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-58000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7727000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7727000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4654000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,594000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2226000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2226000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,660000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2294000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,80000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,808000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,808000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-713000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2500000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1787000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1787000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-136000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15000000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-4000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-521000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14339000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14339000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16933000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,607000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1043000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1043000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,578000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1731000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1655000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1697000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1697000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-170000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-170000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-170000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,176000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,176000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,176000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1703000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,872000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4695000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4695000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,641000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2064000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4402000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1130000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1130000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1076000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22645000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2500000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21221000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21221000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3677000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3677000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3677000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18673000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,952000.0
